Search results
FDA Head Questioned on Zantac’s Hidden Cancer Risk by Top Democrat DeLauro
Bloomberg via Yahoo News· 1 year ago(Bloomberg) -- The Food and Drug Administration’s chief is facing questions from a top lawmaker...
FTSE 100: GSK loses £4.5bn in value on Zantac lawsuit concerns
Yahoo Finance UK· 2 years agoGSK lost billions in value amid litigation concerns over the heartburn drug Zantac. Photo: Drew...
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms
Investor's Business Daily· 2 years agoPharmaceutical stocks GSK, Sanofi and Haleon have wiped out a combined $31 billion in market cap...
GSK Shares Inch Higher After Slumping on Heartburn Drug Litigation Worries
Investing.com via Yahoo Finance· 2 years agoBy Scott Kanowsky Investing.com -- Shares in GSK plc (LON:GSK) rose on Friday, paring back some heavy recent losses, as the British pharmaceutical giant responded to a bout of speculation around ...
These 3 Stocks Escaped Tuesday's Market Downdraft
Motley Fool· 1 year agoThe stock market continued to move lower on Tuesday, building on Monday's losses as investors kept fretting about future monetary policy and economic...
UPDATE 1-Judge weighs key evidence ahead of first Zantac cancer trial
Reuters via Yahoo Finance· 1 year agoLawyers for a man who alleges he developed bladder cancer after taking GSK Plc's heartburn drug Zantac urged a California judge on Thursday to allow expert testimony linking the drug to the ...
Why Pfizer Stock Slipped Today
Motley Fool· 2 years agoWhat happened Shares of Pfizer (NYSE: PFE) slipped 3.3% lower as of the market close on Thursday. The decline resulted from investors' concerns about litigation related to Zantac. The U.S. Food ...
There’s a New Weight-Loss Drug Called Zepbound. Really? Zepbound?
Slate via Yahoo News· 7 months agoThis week, the world simultaneously got yet another weight-loss drug and a reason to wonder why...
FTSE 100 Live: UK economy down 0.6% in June but Q2 beats expectations
Evening Standard via Yahoo News· 2 years agoThe UK economy contracted by an estimated 0.1% in the second quarter, the Office for National...
